Literature DB >> 21228146

Full serotype- and group-specific NS1 capture enzyme-linked immunosorbent assay for rapid differential diagnosis of dengue virus infection.

Xixia Ding1, Dongmei Hu, Yue Chen, Biao Di, Jing Jin, Yuxian Pan, Liwen Qiu, Yadi Wang, Kun Wen, Ming Wang, Xiaoyan Che.   

Abstract

Dengue virus (DENV), a member of the Flavivirus family, has four distinct serotypes (DENV serotype 1 [DENV1], DENV2, DENV3, and DENV4) that require differentiation for the effective prevention of morbid disease. Early and rapid differentiation between flaviviruses remains challenging. Full assays combining four individual, serotype-specific and one group-specific nonstructural protein 1 (NS1) antigen capture enzyme-linked immunosorbent assays (ELISAs) based on monoclonal antibodies (MAbs) against DENV NS1 were developed and validated. The sensitivities and specificities of the full NS1 ELISAs were evaluated with viral cultures and dengue acute-phase sera. Four serotype-specific NS1 ELISAs displayed high specificities for the detection and differentiation of appropriate serotypes. The group-specific NS1 ELISA was broadly reactive with the four dengue virus serotypes. None of the NS1 ELISAs displayed cross-reactivity with the other flaviviruses or samples from febrile patients with non-dengue virus infections. The full serotype- and group-specific MAb-based NS1 capture ELISAs may provide tools for the early detection and typing of dengue infection, which is preferable to reverse transcriptase PCR (RT-PCR) for the rapid differential diagnosis of dengue virus infection in the field.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21228146      PMCID: PMC3067376          DOI: 10.1128/CVI.00462-10

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  20 in total

Review 1.  Dengue diagnosis, advances and challenges.

Authors:  María G Guzmán; Gustavo Kourí
Journal:  Int J Infect Dis       Date:  2004-03       Impact factor: 3.623

2.  Newly synthesized dengue-2 virus nonstructural protein NS1 is a soluble protein but becomes partially hydrophobic and membrane-associated after dimerization.

Authors:  G Winkler; S E Maxwell; C Ruemmler; V Stollar
Journal:  Virology       Date:  1989-07       Impact factor: 3.616

Review 3.  The WHO dengue classification and case definitions: time for a reassessment.

Authors:  Jacqueline L Deen; Eva Harris; Bridget Wills; Angel Balmaseda; Samantha Nadia Hammond; Crisanta Rocha; Nguyen Minh Dung; Nguyen Thanh Hung; Tran Tinh Hien; Jeremy J Farrar
Journal:  Lancet       Date:  2006-07-08       Impact factor: 79.321

4.  Immunoaffinity purification of native dimer forms of the flavivirus non-structural glycoprotein, NS1.

Authors:  A K Falconar; P R Young
Journal:  J Virol Methods       Date:  1990-12       Impact factor: 2.014

5.  Serotype 1-specific monoclonal antibody-based antigen capture immunoassay for detection of circulating nonstructural protein NS1: Implications for early diagnosis and serotyping of dengue virus infections.

Authors:  Hua Xu; Biao Di; Yu-xian Pan; Li-wen Qiu; Ya-di Wang; Wei Hao; Li-juan He; Kwok-yung Yuen; Xiao-yan Che
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

6.  Enzyme-linked immunosorbent assay specific to Dengue virus type 1 nonstructural protein NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infections.

Authors:  Sophie Alcon; Antoine Talarmin; Monique Debruyne; Andrew Falconar; Vincent Deubel; Marie Flamand
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

Review 7.  Immunity and immunopathology in dengue virus infections.

Authors:  I Kurane; F E Ennis
Journal:  Semin Immunol       Date:  1992-04       Impact factor: 11.130

Review 8.  Trends in dengue diagnosis.

Authors:  F R R Teles; D M F Prazeres; J L Lima-Filho
Journal:  Rev Med Virol       Date:  2005 Sep-Oct       Impact factor: 6.989

9.  Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity.

Authors:  D W Vaughn; S Green; S Kalayanarooj; B L Innis; S Nimmannitya; S Suntayakorn; T P Endy; B Raengsakulrach; A L Rothman; F A Ennis; A Nisalak
Journal:  J Infect Dis       Date:  2000-01       Impact factor: 5.226

10.  Multi-country evaluation of the sensitivity and specificity of two commercially-available NS1 ELISA assays for dengue diagnosis.

Authors:  Maria G Guzman; Thomas Jaenisch; Roger Gaczkowski; Vo Thi Ty Hang; Shamala Devi Sekaran; Axel Kroeger; Susana Vazquez; Didye Ruiz; Eric Martinez; Juan C Mercado; Angel Balmaseda; Eva Harris; Efren Dimano; Prisca Susan A Leano; Sutee Yoksan; Elci Villegas; Herminia Benduzu; Iris Villalobos; Jeremy Farrar; Cameron P Simmons
Journal:  PLoS Negl Trop Dis       Date:  2010-08-31
View more
  16 in total

1.  Comparison of plaque- and enzyme-linked immunospot-based assays to measure the neutralizing activities of monoclonal antibodies specific to domain III of dengue virus envelope protein.

Authors:  Lidong Liu; Kun Wen; Jie Li; Dongmei Hu; Yanfen Huang; Liwen Qiu; Jianpiao Cai; Xiaoyan Che
Journal:  Clin Vaccine Immunol       Date:  2011-11-23

2.  Detection of dengue virus NS1 antigen in infected Aedes aegypti using a commercially available kit.

Authors:  Natalia V Voge; Irma Sánchez-Vargas; Carol D Blair; Lars Eisen; Barry J Beaty
Journal:  Am J Trop Med Hyg       Date:  2012-11-26       Impact factor: 2.345

3.  Enzyme-linked immunosorbent assay-format tissue culture infectious dose-50 test for titrating dengue virus.

Authors:  Jie Li; Dong-mei Hu; Xi-xia Ding; Yue Chen; Yu-xian Pan; Li-wen Qiu; Xiao-yan Che
Journal:  PLoS One       Date:  2011-07-25       Impact factor: 3.240

Review 4.  Dengue: Moving from Current Standard of Care to State-of-the-Art Treatment.

Authors:  Victor C Gan
Journal:  Curr Treat Options Infect Dis       Date:  2014

5.  Development of VHH antibodies against dengue virus type 2 NS1 and comparison with monoclonal antibodies for use in immunological diagnosis.

Authors:  Aneela Fatima; Haiying Wang; Keren Kang; Liliang Xia; Ying Wang; Wei Ye; Jufang Wang; Xiaoning Wang
Journal:  PLoS One       Date:  2014-04-21       Impact factor: 3.240

6.  Comparison of surface plasmon resonance, resonant waveguide grating biosensing and enzyme linked immunosorbent assay (ELISA) in the evaluation of a dengue virus immunoassay.

Authors:  Dongmei Hu; Scott R Fry; Johnny X Huang; Xixia Ding; Liwen Qiu; Yuxian Pan; Yue Chen; Jing Jin; Catriona McElnea; Joe Buechler; Xiaoyan Che; Matthew A Cooper
Journal:  Biosensors (Basel)       Date:  2013-07-31

7.  Dengue virus 1 in Buenos Aires from 1999 to 2010: towards local spread.

Authors:  Estefanía Tittarelli; Alicia S Mistchenko; Paola R Barrero
Journal:  PLoS One       Date:  2014-10-24       Impact factor: 3.240

8.  Dengue Virus NS1 Protein as a Diagnostic Marker: Commercially Available ELISA and Comparison to qRT-PCR and Serological Diagnostic Assays Currently Used by the State of Florida.

Authors:  Jason H Ambrose; Shamala Devi Sekaran; Azliyati Azizan
Journal:  J Trop Med       Date:  2017-06-27

9.  Development of a double antibody sandwich ELISA for West Nile virus detection using monoclonal antibodies against non-structural protein 1.

Authors:  Xi-Xia Ding; Xiao-Feng Li; Yong-Qiang Deng; Yong-Hui Guo; Wei Hao; Xiao-Yan Che; Cheng-Feng Qin; Ning Fu
Journal:  PLoS One       Date:  2014-10-10       Impact factor: 3.240

10.  Establishment and Comparison of Two Different Diagnostic Platforms for Detection of DENV1 NS1 Protein.

Authors:  Yin-Liang Tang; Chien-Yu Chiu; Chun-Yu Lin; Chung-Hao Huang; Yen-Hsu Chen; Raul V Destura; Day-Yu Chao; Han-Chung Wu
Journal:  Int J Mol Sci       Date:  2015-11-24       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.